SABBY MANAGEMENT, LLC - Q4 2019 holdings

$361 Million is the total value of SABBY MANAGEMENT, LLC's 71 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 68.8% .

 Value Shares↓ Weighting
BuySPDR S&P 500 ETFput$177,023,000
+497.7%
5,500
+451.1%
49.08%
+207.5%
BuySPDR S&P 500 ETFcall$52,013,000
+247.1%
1,616
+220.0%
14.42%
+78.6%
NewSPDR GOLD TRput$24,836,0001,738
+100.0%
6.88%
SellISHARES TRcall$21,504,000
-9.1%
1,298
-17.0%
5.96%
-53.2%
SellIONIS PHARMACEUTICALS INCcall$17,887,000
-1.7%
2,961
-2.5%
4.96%
-49.4%
SellSPDR GOLD TRcall$15,290,000
-28.7%
1,070
-55.9%
4.24%
-63.3%
GLD NewSPDR GOLD TR$5,366,00037,550
+100.0%
1.49%
SellSPDR S&P BIOTECHput$4,756,000
+23.0%
500
-1.4%
1.32%
-36.7%
SellAMARIN CORP PLCput$4,387,000
+26.0%
2,046
-10.9%
1.22%
-35.2%
BuyAMARIN CORP PLCcall$4,365,000
+50.3%
2,036
+6.3%
1.21%
-22.7%
NewSPDR S&P BIOTECHcall$3,662,000385
+100.0%
1.02%
ONTX BuyONCONOVA THERAPEUTICS INC$3,348,000
+390.9%
8,741,243
+988.8%
0.93%
+152.2%
ODT SellODONATE THERAPEUTICS INC$1,747,000
-27.7%
53,839
-42.0%
0.48%
-62.8%
NewARQULE INC COMcall$1,541,000772
+100.0%
0.43%
NewNABRIVA THERAPEUTICS PLC$1,367,0001,035,667
+100.0%
0.38%
NewSORRENTO THERAPEUTICS INCput$1,173,0003,471
+100.0%
0.32%
GNCA BuyGENOCEA BIOSCIENCES INC$1,114,000
-19.5%
538,359
+12.8%
0.31%
-58.6%
SellOBALON THERAPEUTICS INC$1,084,000
-18.5%
570,418
-16.8%
0.30%
-58.0%
BPTH NewBIO PATH HOLDINGS INC$986,000123,346
+100.0%
0.27%
SellBRAINSTORM CELLput$894,000
-12.0%
2,088
-19.9%
0.25%
-54.7%
PAVMZ SellPAVMED INC*w$836,000
-11.9%
2,152,719
-27.4%
0.23%
-54.6%
NewBIOGEN INCcall$831,00028
+100.0%
0.23%
BuyORAMED PHARMACEUTICALS INCput$804,000
+1769.8%
1,562
+1057.0%
0.22%
+869.6%
SellMICROBOT MED INC$773,000
+74.9%
76,000
-8.8%
0.21%
-10.1%
ATNM SellACTINIUM PHARMACEUTICALS INC$713,000
-64.8%
3,275,718
-62.8%
0.20%
-81.8%
BuyPLURISTEM THERAPEUTICS INCput$708,000
+956.7%
1,796
+903.4%
0.20%
+444.4%
BuyAVEO PHARMACEUTICALS INCput$673,000
+35.1%
10,851
+84.1%
0.19%
-30.2%
BuyTOP SHIPS INC$639,000
+11.7%
799,212
+291.3%
0.18%
-42.5%
BNTC NewBENITEC BIOPHARMA LTDadr$603,000118,285
+100.0%
0.17%
SellAURINIA PHARMACEUTICALScall$590,000
-34.2%
291
-82.6%
0.16%
-66.0%
PHAS SellPHASEBIO PHARMACEUTICALS INC$576,000
+10.8%
94,351
-24.4%
0.16%
-42.9%
AMRN SellAMARIN CORP PLCadr$575,000
+22.3%
26,810
-13.5%
0.16%
-37.2%
PSTV BuyPLUS THERAPEUTICS INC$562,000
+44.5%
234,124
+106.1%
0.16%
-25.7%
INNT SellINNOVATE BIOPHARMACEUTICLS INC$525,000
-60.7%
941,586
-24.6%
0.15%
-79.7%
BuyDIFFUSION PHARMACEUTICALS INC$500,000
-42.2%
1,085,446
+132.0%
0.14%
-70.2%
GHSI NewGUARDION HEALTH SCIENCES INC$439,0001,993,929
+100.0%
0.12%
PULM SellPULMATRIX INC$384,000
-55.7%
446,749
-57.8%
0.11%
-77.3%
XBIO SellXENETIC BIOSCIENCES INC$382,000
-21.1%
265,498
-34.4%
0.11%
-59.4%
SNCA NewSENECA BIOPHARMA INC$378,000381,487
+100.0%
0.10%
SYN SellSYNTHETIC BIOLOGICS INC$348,000
-8.2%
687,304
-17.7%
0.10%
-52.9%
XBIOW SellXENETIC BIOSCIENCES INC*w$297,000
+15.1%
216,789
-18.7%
0.08%
-41.0%
AIM BuyAIM IMMUNOTECH INC$288,000
+104.3%
528,811
+185.6%
0.08%
+5.3%
EARS BuyAURIS MED HLDG LTD$278,000
-39.7%
171,883
+2.6%
0.08%
-69.0%
RWLK BuyREWALK ROBOTICS LTD$273,000
-22.4%
126,280
+9.8%
0.08%
-60.0%
NURO NewNEUROMETRIX INC$275,00063,880
+100.0%
0.08%
NSPR SellINSPIREMD INC$270,000
-33.8%
250,000
-20.3%
0.08%
-65.9%
OTLK NewOUTLOOK THERAPEUTICS INC$229,000388,936
+100.0%
0.06%
PSTI BuyPLURISTEM THERAPEUTICS INC$222,000
+59.7%
56,442
+51.8%
0.06%
-17.3%
NewAVEO PHARMACEUTICALS INCcall$225,0003,625
+100.0%
0.06%
ABEO NewABEONA THERAPEUTICS INC$197,00060,361
+100.0%
0.06%
OGEN SellORAGENICS INC$184,000
-44.9%
351,045
-43.3%
0.05%
-71.7%
BLIN  BRIDGELINE DIGITAL INC COM$169,000
-19.5%
110,0000.0%0.05%
-58.4%
 VIKING THERAPEUTICS INCcall$160,000
+15.9%
2000.0%0.04%
-40.5%
DMPI BuyDELMAR PHARMACEUTICALS INC$153,000
-70.9%
1,226,022
+28.9%
0.04%
-85.2%
GNPX SellGENPREX INC$142,000
-69.3%
443,441
-23.2%
0.04%
-84.3%
LPCN NewLIPOCINE INC$142,000367,693
+100.0%
0.04%
CLSN SellCELSION CORP$117,000
-51.2%
68,560
-56.1%
0.03%
-75.2%
SHIPZ SellSEANERGY MARITIME HOLDINGS CORP*w$100,000
-27.5%
907,999
-1.0%
0.03%
-62.2%
VBLT SellVASCULAR BIOGENICS LTD$96,000
-40.7%
80,295
-32.9%
0.03%
-69.0%
NewAKERS BIOSCIENCES INC$93,00029,100
+100.0%
0.03%
SRNE NewSORRENTO THERAPEUTICS INC$92,00027,178
+100.0%
0.03%
AEZS BuyAETERNA ZENTARIS INC$93,000
+25.7%
101,976
+41.5%
0.03%
-35.0%
MDGSW  MEDIGUS LTD*w$93,000
-7.9%
1,008,4440.0%0.03%
-51.9%
ALT BuyALTIMMUNE INC COM$85,000
+4.9%
44,855
+7.4%
0.02%
-45.5%
SPHS NewSOPHIRIS BIO INC$68,00042,378
+100.0%
0.02%
NewTENAX THERAPEUTICS INC$61,00043,164
+100.0%
0.02%
 CELSION CORPput$31,000
+10.7%
1840.0%0.01%
-40.0%
RBZHF NewREEBONZ HLDG LTD$29,00025,000
+100.0%
0.01%
SNES  SENESTECH INC$27,000
-44.9%
48,2940.0%0.01%
-73.1%
SHIP SellSEANERGY MARITIME HOLDINGS CORP$27,000
-95.4%
49,999
-95.9%
0.01%
-97.8%
SellADAMIS PHARMACEUTICALS CORPput$8,0000.0%111
-2.6%
0.00%
-50.0%
BNTCW ExitBENITEC BIOPHARMA LTD*w$0-51,449
-100.0%
-0.00%
ExitTITAN PHARMACEUTICALS INCput$0-106
-100.0%
-0.00%
ONTXW ExitONCONOVA THERAPEUTICS INC*w$0-631,812
-100.0%
-0.01%
TTNP ExitTITAN PHARMACEUTICALS INC$0-83,218
-100.0%
-0.01%
ExitALTIMMUNE INC COMput$0-134
-100.0%
-0.01%
ExitCELSION CORPcall$0-260
-100.0%
-0.02%
ExitSESEN BIO INCput$0-365
-100.0%
-0.02%
BLCM ExitBELLICUM PHARMACEUTICALS INC$0-42,007
-100.0%
-0.02%
TMDI ExitTITAN MEDICAL INC$0-41,085
-100.0%
-0.02%
VISL ExitVISLINK TECHNOLOGIES INC$0-115,314
-100.0%
-0.03%
EYEN ExitEYENOVIA INC$0-17,900
-100.0%
-0.04%
ADMP ExitADAMIS PHARMACEUTICALS CORP$0-183,359
-100.0%
-0.07%
ExitCEL SCI CORPcall$0-187
-100.0%
-0.09%
ABILF ExitABILITY INC$0-312,642
-100.0%
-0.10%
RKDA ExitARCADIA BIOSCIENCES INC$0-50,000
-100.0%
-0.13%
CYTR ExitCYTRX CORP$0-729,450
-100.0%
-0.13%
OPTT ExitOCEAN PWR TECHNOLOGIES INC$0-150,000
-100.0%
-0.14%
ExitINPIXON$0-2,360,220
-100.0%
-0.15%
HEPA ExitHEPION PHARMACEUTICALS INC$0-115,000
-100.0%
-0.15%
NURO ExitNEUROMETRIX INC$0-934,212
-100.0%
-0.16%
ExitKADMON HLDGS INCput$0-114
-100.0%
-0.17%
CUR ExitNEURALSTEM INC$0-204,823
-100.0%
-0.18%
ExitORAMED PHARMACEUTICALS INCcall$0-1,120
-100.0%
-0.19%
ALRN ExitAILERON THERAPEUTICS INC$0-549,900
-100.0%
-0.20%
AVCO ExitAVALON GLOBOCARE CORP$0-197,119
-100.0%
-0.20%
ADXS ExitADVAXIS INC$0-1,521,982
-100.0%
-0.22%
VBIV ExitVBI VACCINES INC$0-876,157
-100.0%
-0.22%
ExitGENOCEA BIOSCIENCES INCcall$0-1,481
-100.0%
-0.23%
VXRT ExitVAXART INC$0-1,197,710
-100.0%
-0.23%
SEEL ExitSEELOS THERAPEUTICS INC$0-491,237
-100.0%
-0.24%
SOLO ExitELECTRAMECCANICA VEHS CORP$0-288,408
-100.0%
-0.32%
ORMP ExitORAMED PHARMACEUTICALS INC$0-185,800
-100.0%
-0.32%
CTXR ExitCITIUS PHARMACEUTICALS INC$0-845,432
-100.0%
-0.34%
ExitCEL SCI CORPput$0-855
-100.0%
-0.41%
BHVN ExitBIOHAVEN PHARMACEUTICAL HLDG CO LTD$0-19,850
-100.0%
-0.45%
BNTC ExitBENITEC BIOPHARMA LTDadr$0-1,365,615
-100.0%
-0.52%
ExitCORMEDIX INCput$0-1,936
-100.0%
-0.67%
ARCT ExitARCTURUS THERAPEUTICS HLDG INC$0-124,843
-100.0%
-0.69%
CJJD ExitCHINA JO-JO DRUGSTORES INC$0-1,325,299
-100.0%
-0.86%
CRMD ExitCORMEDIX INC$0-249,198
-100.0%
-0.86%
ExitBIOHAVEN PHARMACEUTICAL HLDG CO LTDput$0-412
-100.0%
-0.93%
TEUM ExitPARETEUM CORP$0-2,248,578
-100.0%
-1.56%
ExitISHARES TRput$0-1,578
-100.0%
-12.87%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings